We are live on ! Find out more
HURA icon

TuHURA Biosciences
HURA

8 hedge funds and large institutions have $190K invested in TuHURA Biosciences in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

152% more capital inflows, than outflows

Capital inflows: $140K | Capital outflows: $55.4K

60% more funds holding

Funds holding: 5 → 8 (+3)

0.81% more ownership

Funds ownership: 1.59% → 2.4% (+0.81%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$57.6K
2
Citadel Advisors
Citadel Advisors
Florida
+$16.6K
3
Northern Trust
Northern Trust
Illinois
+$8.96K
4
UBS Group
UBS Group
Switzerland
+$6.4K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$38.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17K

HURA Hedge Fund Activity: Q2 2020 in Review

8 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2020, worth a combined $190K — up 164% from $71.9K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HURA positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $57.6K. The largest seller was Barclays, cutting an estimated $38.4K.

  • 8 institutional investors held TuHURA Biosciences (HURA) as of Q2 2020, up from 5 in Q1 2020.
  • Funds reported $190K of TuHURA Biosciences stock for Q2 2020, up 164% quarter-over-quarter.
  • 4 funds opened new TuHURA Biosciences positions in Q2 2020 and 1 closed out, a net change of +3 holders.
  • The largest TuHURA Biosciences buyer in Q2 2020 was Renaissance Technologies, an estimated $57.6K added.
  • The largest TuHURA Biosciences seller in Q2 2020 was Barclays, an estimated $38.4K sold.

Based on aggregated 13F filings for Q2 2020.